Editorial: Biologically active products as therapeutic options for the treatment of cardiovascular diseases related to liver injury

Arquimedes Gasparotto Junior; Francislaine Aparecida Dos Reis Lívero; Alexandra Acco

doi:10.3389/fphar.2022.1041020

Editorial: Biologically active products as therapeutic options for the treatment of cardiovascular diseases related to liver injury

Front Pharmacol. 2022 Oct 24:13:1041020. doi: 10.3389/fphar.2022.1041020. eCollection 2022.

Authors

Arquimedes Gasparotto Junior¹, Francislaine Aparecida Dos Reis Lívero², Alexandra Acco³

Affiliations

¹ Federal University of Grande Dourados, Dourados, MS, Brazil.
² Paranaense University, Umuarama, PR, Brazil.
³ Federal University of Paraná, Curitiba, PR, Brazil.

No abstract available

Keywords: MAFLD (metabolic associated fatty liver disease); ethnomedicine; myocardia infarction; natural products; reverse cholesterol transport (RCT).

Publication types

Editorial